The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell and gene therapies. Their core ExPERT ATx, sTX, GTx, and VLx tools use ...

Hot boards! I’m at the age where I at least try to maintain some semblance of relevance to the modern age, but I cannot abide ...

Here, the authors analyze ancient human DNA from ShanDong, China to reveal two waves of gene flow from Yellow River populations in the DaWenKou (6-4 kBP) and early dynastic (3.5-1.5 kBP ...

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

USC has received a $6m grant from the California Institute for Regenerative Medicine (CIRM) to advance a new gene therapy for ...

Black History Month is a time for reflection and action. The Annual Black Legacy Awards will honor the achievenements of ...

A gene that has been coined "the guardian of the genome," when inactivated ... preventing other plumbers from getting near, speeding up the flow of water, and adding new leaky pipes around your home, ...

The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with nearly 17,000 ...

International collaborations, refined gene-editing protocols, and targeted immunologic maneuvers keep the cancer gene therapy ...